Barricaid Webinars – Make the First Spine Surgery the Last

Barricaid is a proven technology that reduces reoperations for reherniations by 81% in a well-defined patient population. Learn about the clinical efficacy and superiority RCT for Barricaid from Oscar Yeh, Chief Operating Officer of Intrinsic Therapeutics, Inc in this payor-focused webinar, recorded on 12/9/21.

For full benefit/risk information, please visit PPT22 Rev. A

If Barricaid is right for you, we can help.

Sign up to receive future updates and information on the Barricaid procedure.
  • This field is for validation purposes and should be left unchanged.

WordPress Lightbox Plugin